Zaman, S, Fortea, J. Focal Point The crucial history of Down syndrome. LANCET NEUROLOGY. 2022; 21(3)DOI:10.1016/S1474-4422(22)00047-3. PMID:35182507. IF:48.000(Q1/1D).

Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Camposs, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Terrancle, A, Prefasi, D, Lleo, A, Maurino, J. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2022; 90(2)DOI:10.3233/JAD-220696. PMID:36155523. IF:4.000(Q2/4D).

Gómez de San José N., Goossens J., Al Shweiki M.R., Halbgebauer S., Oeckl P., Steinacker P., Danzer K.M., Graf H., Schönfeldt-Lecuona C., Belbin O., Lleó A., Vanmechelen E., Otto M.. Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders. JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 156DOI:10.1016/j.jpsychires.2022.10.010. PMID:36323141. IF:4.800(Q2/4D).

del Campo M., Peeters C.F.W., Johnson E.C.B., Vermunt L., Hok-A-Hin Y.S., van Nee M., Chen-Plotkin A., Irwin D.J., Hu W.T., Lah J.J., Seyfried N.T., Dammer E.B., Herradon G., Meeter L.H., van Swieten J., Alcolea D., Lleó A., Levey A.I., Lemstra A.W., Pijnenburg Y.A.L., Visser P.J., Tijms B.M., van der Flier W.M., Teunissen C.E.. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2022; 2(11)DOI:10.1038/s43587-022-00300-1. PMID:37118088. IF:(Q/D).

Valle-Tamayo N., Pérez-González R., Chiva-Blanch G., Belbin O., Serrano-Requena S., Sirisi S., González A.C., Giró O., Sánchez-Aced É., Dols-Icardo O., Alcolea D., Carmona-Iragui M., Jimenez A., Lleó A., Fortea J., Iulita M.F.. Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma. Jove-Journal of Visualized Experiments. 2022; 2022(186)DOI:10.3791/64107. PMID:35993755. IF:1.200(Q3/8D).

Ali M., Sung Y.J., Wang F., Fernández M.V., Morris J.C., Fagan A.M., Blennow K., Zetterberg H., Heslegrave A., Johansson P.M., Svensson J., Nellgård B., Lleó A., Alcolea D., Clarimon J., Rami L., Molinuevo J.L., Suárez-Calvet M., Morenas-Rodríguez E., Kleinberger G., Haass C., Ewers M., Levin J., Farlow M.R., Perrin R.J., Cruchaga C.. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk. PLoS One. 2022; 17DOI:10.1371/journal.pone.0267298. PMID:35617280. IF:3.700(Q2/4D).